2015-2019 Global Chlamydia Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Strategies - Competitive Landscape, Supplier Shares, Country Volume and Sales Segment Forecasts
The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.
Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed.
The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Chlamydia tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 184 pages and 15 tables
Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed.
The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Chlamydia tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 184 pages and 15 tables
I. INTRODUCTION
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
CHLAMYDIA PSITTACI
CHLAMYDIA PNEUMONIAE
CHLAMYDIA TRACHOMATIS
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
POLYMERASE CHAIN REACTION
Robotics
Temperature Cyclers
PCR Variations
IMMUNO - PCR
QC - PCR
DAP - PCR
LIGASE CHAIN REACTION
BRANCHED DNA
Q - BETA REPLICASE
NUCLEIC - ACID SEQUENCE - BASED
STRAND DISPLACEMENT ACTIVATION
SELF - SUSTAINED SEQUENCE REPLICASE
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
OVERVIEW
ELISA
DOT IMMUNOBINDING ASSAYS
CAPILLARY IMMUNOASSAYS
PARTICLE - MEMBRANE CAPTURE IMMUNOASSAYS
ENZYME AMPLIFICATION
c. Fluorescent Immunoassays
FLUORESCENCE POLARIZATION
TIME - RESOLVED PULSE FLUORESCENCE
d. Luminescence
CHEMILUMINESCENCE
BIOLUMINESCENCE
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Applera
Beckman Coulter
Becton Dickinson
Binding Site
Biomerica
Biokit
bioMerieux
Bio - Rad
Biotrol
Biosite
Biotest
Caliper Technologies
Cepheid
Chemicon
Daiichi
DiaSorin
Diagast
Diamedix
Digene
Eiken
Enzo Biochem
Fujirebio
GenBio
Gene - Tec
Hemagen
Immunetics
Innogenetics
Inverness - J&J
Meridian
Nanogen
Nissui
Olympus
Provalis
Roche
Saliva Diagnostic
SeraCare
Siemens
Third Wave Technologies
Thermo Fisher
Tosho
Trinity Biotech
Tropix
Wampole Labs
Zenith
Zeus
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
CHLAMYDIA PSITTACI
CHLAMYDIA PNEUMONIAE
CHLAMYDIA TRACHOMATIS
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
POLYMERASE CHAIN REACTION
Robotics
Temperature Cyclers
PCR Variations
IMMUNO - PCR
QC - PCR
DAP - PCR
LIGASE CHAIN REACTION
BRANCHED DNA
Q - BETA REPLICASE
NUCLEIC - ACID SEQUENCE - BASED
STRAND DISPLACEMENT ACTIVATION
SELF - SUSTAINED SEQUENCE REPLICASE
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
OVERVIEW
ELISA
DOT IMMUNOBINDING ASSAYS
CAPILLARY IMMUNOASSAYS
PARTICLE - MEMBRANE CAPTURE IMMUNOASSAYS
ENZYME AMPLIFICATION
c. Fluorescent Immunoassays
FLUORESCENCE POLARIZATION
TIME - RESOLVED PULSE FLUORESCENCE
d. Luminescence
CHEMILUMINESCENCE
BIOLUMINESCENCE
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Applera
Beckman Coulter
Becton Dickinson
Binding Site
Biomerica
Biokit
bioMerieux
Bio - Rad
Biotrol
Biosite
Biotest
Caliper Technologies
Cepheid
Chemicon
Daiichi
DiaSorin
Diagast
Diamedix
Digene
Eiken
Enzo Biochem
Fujirebio
GenBio
Gene - Tec
Hemagen
Immunetics
Innogenetics
Inverness - J&J
Meridian
Nanogen
Nissui
Olympus
Provalis
Roche
Saliva Diagnostic
SeraCare
Siemens
Third Wave Technologies
Thermo Fisher
Tosho
Trinity Biotech
Tropix
Wampole Labs
Zenith
Zeus
LIST OF TABLES
Major Companies Developing or Marketing Chlamydia Tests
France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Diagnostics Sales by Major Supplier
Germany Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Chlamydia Diagnostics Sales by Major Supplier
Italy Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Chlamydia Diagnostics Sales by Major Supplier
Japan Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Chlamydia Diagnostics Sales by Major Supplier
Spain Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Chlamydia Diagnostics Sales by Major Supplier
U.K. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Chlamydia Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chlamydia Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Chlamydia Tests
France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Diagnostics Sales by Major Supplier
Germany Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Chlamydia Diagnostics Sales by Major Supplier
Italy Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Chlamydia Diagnostics Sales by Major Supplier
Japan Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Chlamydia Diagnostics Sales by Major Supplier
Spain Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Chlamydia Diagnostics Sales by Major Supplier
U.K. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Chlamydia Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chlamydia Diagnostics Sales by Major Supplier
